VL
Insider
Voss Capital, LP
10% ownerVoss Capital, LP (10% owner) filed 12 Form 4 reports as a reporting entity in the trailing twelve months (9 purchases, 3 sales, 3 filed past the two-business-day deadline), most often in Flywire Corporation (FLYW). Across 9 priced purchase filings, the average 21-session return was +3.4% from execution and -3.6% from disclosure (delay-adjusted; derived). The largest single filing was $14.6M of PAR (524,064 sh across 9 lots, as filed), executed Jan 14.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
+3.4%
avg across 9 priced filings
Delay-adjustediThe same average, entered at disclosure dates
-3.6%
same 9 filings, from disclosure
Filings, ttm
12
9 buys · 3 sells · 3 late
Median delay
4d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$50.5M
shares × price, as filed
Last traded
Aug 27
Filed Aug 28
Median ADV $21.9M across their filed names
Impact on $10,000 · 12M
$7,292 (-27.1%)
S&P 500 $11,725 (+17.2%) · 44.3 pts behind
Voss Capital, LP
S&P 500
Compounded across filings from disclosure dates · past 12 months
Open performance→Volume by month
Buys $41.2M
Sells $9.3M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Technology
9 filings
Consumer Cyclical
1 filing
Not on file
2 filings
Sector per market data · by filing · past 12 months
Most traded names
FLYWRecent filings
PARPURCHASE
PAR Technology Corporation
View filing →
$7.1M196,035 sh across 4 lots
Exec Dec 30 2025
Filed Jan 7 · 6:09 PM ET † FLYWPURCHASE Flywire Corporation View filing → $3.2M
226,112 sh across 2 lots
Exec Dec 30 2025
Filed Jan 7 · 5:59 PM ET † RNTXPURCHASE Rein Therapeutics, Inc. View filing → $128K
104,183 sh × $1.22
Exec Nov 14 2025
Filed Nov 18 2025 · 5:30 PM ET RNTXPURCHASE Rein Therapeutics, Inc. View filing → $375K
271,034 sh across 2 lots
Exec Oct 27 2025
Filed Oct 28 2025 · 6:45 PM ET